Regenerative Medical Technology Group Inc. RMTG
Set alert
0.04 USD +0.01 +16.67%
As of Nov 2, 12:12 PM ET
0.035 Day range 0.035
0.0189 52-week range 0.125
- YTD
- -28.57%
- 1 year
- -28.93%
- Open
- 0.035
- Prev close
- 0.03
- Mkt cap
- 480.86K
- Vol
- 10.00K
- Avg vol
- 55.91K
- EPS
- -0.70
- P/E
- 0.00
More statistics
- Low
- 0.035
- High
- 0.035
3M chart
Signals (14)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 3, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 21, 2026 | 2 months ago |
| RSI: Overbought | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 11, 2026 | 2 months ago |
News
- RMTG's ISSCA Division Returns to São Paulo for a Second Brazil Congress, November 20-21
- RMTG to Go Ringside at BKFC This Weekend to Capture Content for Its "RMTG Brief" Investor-Awareness Campaign
- RMTG's ISSCA Division Expands Global Online Academy With Ten New Curriculum Tracks
- RMTG Broadens Longevity Footprint With New ISSCA Certification Across Adjunctive Therapies
- RMTG Expands Peptide Education Platform With ISSCA Peptide Certification 2.0 and New Physician Reference Guides
- RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico
- RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
- Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
- RMTG's Cellgenic Division Begins Local Commercial Activity in Colombia, Subject to Colombian Regulatory Requirements
- Cellgenic Establishes Local Commercial Presence in Brazil
Your note
Sign in to keep a note on RMTG — it syncs with the Stock Master app.